Thursday, October 5, 2017: 10:30 AM-12:00 PM
At the conclusion of this session, participants will be able to:
- review the current data supporting the use of probiotics for gastrointestinal disease.
- review the data to support the use of prebiotics or probiotics in the immunocompromised host.
- review the existing data to inform which probiotic to use for various conditions.
Academicians, Clinicians, Fellows, Healthcare workers, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Medical students and residents, Members-in-training, Pharmacists, Public health practitioners, Researchers
Adult ID, Pediatric ID
David Greenberg, MD, FIDSA, University of Texas Southwestern Medical Center
Bonnie Prokesch, MD, UT Southwestern
Maximum of 1.50 hours of AMA PRA Category 1 Credit™
ACPE 1.5 knowledge-based contact hours of pharmacy CE
Patent, Copyright, License
Licensing agreement or royalty